ARTICLE | Clinical News
Angiomax vs Heparin data released
September 4, 2001 7:00 AM UTC
The Medicines Co. (MDCO) reported results of HERO-2, a randomized, open label Phase IIIb trial comparing the company's Angiomax bivalirudin with heparin in 17,073 patients receiving fibrinolysis for m...